PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26225F0062Vasdhcs illuccix — Telix Pharmaceuticals (Us) Inc

Telix Pharmaceuticals (Us) Inc holds $6.9M across 17 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award under parent 36F79722D0197. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Feb 10, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

262-Network Contract Office 22 (36C262)

Awarding office

Telix Pharmaceuticals (Us) Inc

Recipient

Feb 10, 2025

PoP end

$162K

Obligated

$198K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Telix Pharmaceuticals (Us) Inc — $90

Contract facts

Federal

Contract number36C26225F0062

Also listed as36C262-25-F-0062

Also listed as36F79722D0197-36C26225F0062

Agency262-Network Contract Office 22 (36C262)

Awarding office262-Network Contract Office 22 (36C262)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentTelix Pharmaceuticals (Us) Inc

CAGE8CP27

UEINMRHMBK4YTH7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79722D0197

Place of performanceDUBLIN OH

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startNov 1, 2024

PoP end (current)Feb 10, 2025

Obligated$162K

Current value$198K

Potential value$198K

VASDHCS ILLUCCIX is a federal award for 262-Network Contract Office 22 (36C262) held by Telix Pharmaceuticals (Us) Inc. Estimated value $198K ($162K obligated). Current period of performance ends Feb 10, 2025. Last award drew 1 bidder. Place of performance: DUBLIN OH.

Recompete timing

Public

● Past PoP end (557 days ago)

Current PoP ended Feb 10, 2025 (557 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Telix Pharmaceuticals (Us) Inc — $6.9M obligated across 17 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$6.9M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

36C24826N0054

ILLUCCIX

$1.8M

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26225F0062?

36C26225F0062 (Vasdhcs illuccix) is a 262-Network Contract Office 22 (36C262) award with a potential value of $198K, currently held by Telix Pharmaceuticals (Us) Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C262-25-F-0062?

36C262-25-F-0062 is the dashed form of PIID 36C26225F0062 (Vasdhcs illuccix), held by Telix Pharmaceuticals (Us) Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26225F0062?

262-Network Contract Office 22 (36C262) awarded 36C26225F0062 to Telix Pharmaceuticals (Us) Inc (potential $198K).

Who is the incumbent on 36C26225F0062?

Telix Pharmaceuticals (Us) Inc is the incumbent with $6.9M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Feb 10, 2025.

When does Telix Pharmaceuticals (Us) Inc’s 36C26225F0062 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 10, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Mar 10, 2025